Insulin Gene Therapy for Treating Type I Diabetes Mellitus: History, Progress and Future Challenges
Journal: Journal of Diabetes Research and Therapy (Vol.6, No. 1)Publication Date: 2020-03-02
Authors : Tugce Akcan Tausif Alam Hans W Sollinger;
Page : 1-7
Keywords : Gene therapy; Insulin; Type 1 diabetes mellitus; Adeno-associated virus;
Abstract
Type 1 Diabetes Mellitus (T1DM) results from the autoimmune destruction of insulin-producing pancreatic β cells. Despite advances in our understanding of both the pathogenesis and management of diabetes and treatment options, which mainly include injectable insulin and whole pancreas transplant, these advancements remain unsatisfactory and only a small portion of patients achieve their glycemic goals. Insulin gene therapy refers to the development of β cell substitutes by introducing an insulin producing gene into endogenous cell populations that do not normally produce insulin. This strategy has the promise to overcome the limitations of current treatments. Here, we present an overview of the history of insulin gene therapy and review current achievements. We also briefly discuss areas for improvement and potential future directions.
Other Latest Articles
- Effect of Bee Honey on Blood Glucose Level of Sudanese Patients with Type 2 Diabetes Mellitus
- Anti-Diabetic and Haematinic Effects of Beet Root Juice (Beta vulgaris L.) in Alloxan Induced Type-1 Diabetic Albino Rats
- Adolescence and Type 1 Diabetes: Evaluation and Psychological Treatment of a Case with Intellectual Development Disorder
- A Meta-Analysis on Adverse Event Reporting across Clinical Trials within Diabetic Drug Classes over Time
- Evaluate Performance of Prodigy Glucose Meter versus Reference Hexokinase Method in Addis Ababa, Ethiopia
Last modified: 2020-08-12 00:37:05